Showing posts with label report. Show all posts
Showing posts with label report. Show all posts

Friday, January 28, 2011

Update: download FluView maps and overview report for the week ending 20 February 2010, in

Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request

FluView: A Weekly Influenza Surveillance Report Prepared by the Influenza Division

All data are preliminary and may change as more reports are received.

During week 47 (November 21-27, 2010), influenza activity in the United States remained relatively low overall, but increased slightly in the Southeast.

Of the 3,430 specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division, 366 (10.7%) were positive for influenza.The proportion of deaths attributed to pneumonia and influenza (P&I) was below the epidemic threshold. No influenza-associated pediatric deaths were reported. The proportion of outpatient visits for influenza-like illness (ILI) was 1.9%, which is below the national baseline of 2.5%. One of the 10 regions (Region 4) reported ILI above region-specific baseline levels; one state experienced high ILI activity; one state experienced low ILI activity, and 48 states experienced minimal ILI activity.The geographic spread of influenza in one state was reported as regional, Puerto Rico and nine states reported local activity; the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states reported sporadic activity; and seven states reported no influenza activity.HHS Surveillance Regions*Data for current weekData cumulative since October 3, 2010 (Week 40)Out-patient ILI†% positive for flu‡Number of jurisdictions reporting regional or widespread activity§A (H3)2009 A (H1N1)A(Subtyping not performed)BPediatric Deaths

WHO and NREVSS collaborating laboratories located in all 50 states and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and the number positive by influenza type and subtype. The results of tests performed during the current week are summarized in the table below.

Positive specimens by type/subtype

The District of Columbia and 44 states from all 10 surveillance regions have reported laboratory-confirmed influenza this season. Region 4 in the Southeastern United States has accounted for 1,231 (69.7%) of all 1,766 reported influenza viruses this season, including 680 (88.2%) of the 771 influenza B viruses.


INFLUENZA Virus Isolated
View WHO-NREVSS Regional Bar Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

This system tracks weekly counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was implemented on August 30, 2009, during the 2009 pandemic, and ended on April 4, 2010. AHDRA surveillance during the 2010-11 season is being continued on a voluntary basis and 11 jurisdictions reported during week 47. From October 3-November 27, 2010, 271 laboratory-confirmed influenza associated hospitalizations and four laboratory-confirmed influenza associated deaths were reported to CDC.


Aggregate Hospital and Death Reporting
View Full Screen | View Chart Data | View PowerPoint Presentation

CDC has antigenically characterized 18 influenza viruses [four 2009 influenza A (H1N1) viruses, eight influenza A (H3N2) viruses, and six influenza B viruses] collected by U.S. laboratories since October 1, 2010.

Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B virus isolates for resistance to neuraminidase inhibitors (oseltamivir and zanamivir) is performed at CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for a single known mutation in the neuraminidase protein of the virus that confers oseltamivir resistance (H275Y). The data summarized below combine the results of both test methods and includes samples that were tested as part of routine surveillance purposes; it does not include diagnostic testing specifically done because of clinical suspicion of antiviral resistance.

High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B viruses) circulating globally. As a result of the sustained high levels of resistance, data from adamantane resistance testing are not presented weekly in the table below.

Samples tested (n)Resistant Viruses,
Number (%)Samples tested (n)Resistant Viruses, Number (%)

To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of the need to continue hand and cough hygiene measures for the duration of any symptoms of influenza, even while taking antiviral medications. Additional information on antiviral recommendations for treatment and chemoprophylaxis of influenza virus infection is available at http://www.cdc.gov/flu/antivirals/index.htm.

During week 47, 6.0% of all deaths reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was below the epidemic threshold of 7.2% for week 47.

Pneumonia And Influenza Mortality
View Full Screen | View PowerPoint Presentation

No influenza-associated pediatric deaths were reported to CDC during week 47.

One death, associated with an influenza A virus for which the subtype was not determined, occurring during the 2010-2011 season has been reported.


Influenza-Associated Pediatric Mortality
View Full Screen | View PowerPoint Presentation

The Influenza Hospitalization Network (FluSurv-NET) conducts surveillance for population-based, laboratory-confirmed influenza-related hospitalizations in children (persons younger than 18 years) and adults. The network covers over 80 counties in the 10 Emerging Infections Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and six additional states (ID, MI, OH, OK, RI and UT). FluSurv-NET estimated hospitalization rates will be updated every two weeks starting later this season.

Nationwide during week 47, 1.9% of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness (ILI). This percentage is below the national baseline of 2.5%.

national levels of ILI and ARI
View ILINet Regional Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

On a regional level, the percentage of outpatient visits for ILI ranged from 0.4% to 3.2% during week 47. One of the 10 regions (Region 4) reported a proportion of outpatient visits for ILI above their region-specific baseline levels.

Data collected in ILINet are used to produce a measure of ILI activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI and are compared to the average percent of ILI visits that occur during spring and fall weeks with little or no influenza virus circulation. Activity levels range from minimal, which would correspond to ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI activity from outpatient clinics being much higher than the average. Because the clinical definition of ILI is very general, not all ILI is caused by influenza; however, when combined with laboratory data, the information on ILI activity provides a clear picture of influenza activity in the United States.

During week 47, the following ILI activity levels were experienced:

One state (Georgia) experienced high ILI activity. While influenza-like illness is a non-specific term and may be caused by a variety of organisms, the increase in ILI in Georgia has occurred at the same time as a significant increase in the number of reported influenza B virus infections.New York City and one state (Alabama) experienced low ILI activity.Forty-eight states experienced minimal ILI activity (Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).Data were insufficient to calculate an ILI activity level from the District of Columbia.

Click on map to launch interactive tool

Click on map to launch interactive tool

The influenza activity reported by state and territorial epidemiologists indicates geographic spread of influenza viruses, but does not measure the severity of influenza activity.

During week 47, the following influenza activity was reported:

Regional influenza activity was reported by one state (Georgia).Local influenza activity was reported by Puerto Rico and nine states (Alabama, Connecticut, Hawaii, Louisiana, Mississippi, New York, Oklahoma, Pennsylvania, and South Carolina).Sporadic influenza activity was reported by the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states (Alaska, Arizona, Arkansas, California, Colorado, Florida, Idaho, Illinois, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oregon, Rhode Island, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).No influenza activity was reported by seven states (Delaware, Iowa, Maine, Nebraska, North Dakota, South Dakota, and Vermont).

U. S. Map for Weekly Influenza Activity


View the original article here

Saturday, January 22, 2011

Update: download FluView maps and overview report for the week ending 17 April 2010

Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request

FluView: A Weekly Influenza Surveillance Report Prepared by the Influenza Division

All data are preliminary and may change as more reports are received.

During week 47 (November 21-27, 2010), influenza activity in the United States remained relatively low overall, but increased slightly in the Southeast.

Of the 3,430 specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division, 366 (10.7%) were positive for influenza.The proportion of deaths attributed to pneumonia and influenza (P&I) was below the epidemic threshold. No influenza-associated pediatric deaths were reported. The proportion of outpatient visits for influenza-like illness (ILI) was 1.9%, which is below the national baseline of 2.5%. One of the 10 regions (Region 4) reported ILI above region-specific baseline levels; one state experienced high ILI activity; one state experienced low ILI activity, and 48 states experienced minimal ILI activity.The geographic spread of influenza in one state was reported as regional, Puerto Rico and nine states reported local activity; the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states reported sporadic activity; and seven states reported no influenza activity.HHS Surveillance Regions*Data for current weekData cumulative since October 3, 2010 (Week 40)Out-patient ILI†% positive for flu‡Number of jurisdictions reporting regional or widespread activity§A (H3)2009 A (H1N1)A(Subtyping not performed)BPediatric Deaths

WHO and NREVSS collaborating laboratories located in all 50 states and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and the number positive by influenza type and subtype. The results of tests performed during the current week are summarized in the table below.

Positive specimens by type/subtype

The District of Columbia and 44 states from all 10 surveillance regions have reported laboratory-confirmed influenza this season. Region 4 in the Southeastern United States has accounted for 1,231 (69.7%) of all 1,766 reported influenza viruses this season, including 680 (88.2%) of the 771 influenza B viruses.


INFLUENZA Virus Isolated
View WHO-NREVSS Regional Bar Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

This system tracks weekly counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was implemented on August 30, 2009, during the 2009 pandemic, and ended on April 4, 2010. AHDRA surveillance during the 2010-11 season is being continued on a voluntary basis and 11 jurisdictions reported during week 47. From October 3-November 27, 2010, 271 laboratory-confirmed influenza associated hospitalizations and four laboratory-confirmed influenza associated deaths were reported to CDC.


Aggregate Hospital and Death Reporting
View Full Screen | View Chart Data | View PowerPoint Presentation

CDC has antigenically characterized 18 influenza viruses [four 2009 influenza A (H1N1) viruses, eight influenza A (H3N2) viruses, and six influenza B viruses] collected by U.S. laboratories since October 1, 2010.

Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B virus isolates for resistance to neuraminidase inhibitors (oseltamivir and zanamivir) is performed at CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for a single known mutation in the neuraminidase protein of the virus that confers oseltamivir resistance (H275Y). The data summarized below combine the results of both test methods and includes samples that were tested as part of routine surveillance purposes; it does not include diagnostic testing specifically done because of clinical suspicion of antiviral resistance.

High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B viruses) circulating globally. As a result of the sustained high levels of resistance, data from adamantane resistance testing are not presented weekly in the table below.

Samples tested (n)Resistant Viruses,
Number (%)Samples tested (n)Resistant Viruses, Number (%)

To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of the need to continue hand and cough hygiene measures for the duration of any symptoms of influenza, even while taking antiviral medications. Additional information on antiviral recommendations for treatment and chemoprophylaxis of influenza virus infection is available at http://www.cdc.gov/flu/antivirals/index.htm.

During week 47, 6.0% of all deaths reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was below the epidemic threshold of 7.2% for week 47.

Pneumonia And Influenza Mortality
View Full Screen | View PowerPoint Presentation

No influenza-associated pediatric deaths were reported to CDC during week 47.

One death, associated with an influenza A virus for which the subtype was not determined, occurring during the 2010-2011 season has been reported.


Influenza-Associated Pediatric Mortality
View Full Screen | View PowerPoint Presentation

The Influenza Hospitalization Network (FluSurv-NET) conducts surveillance for population-based, laboratory-confirmed influenza-related hospitalizations in children (persons younger than 18 years) and adults. The network covers over 80 counties in the 10 Emerging Infections Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and six additional states (ID, MI, OH, OK, RI and UT). FluSurv-NET estimated hospitalization rates will be updated every two weeks starting later this season.

Nationwide during week 47, 1.9% of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness (ILI). This percentage is below the national baseline of 2.5%.

national levels of ILI and ARI
View ILINet Regional Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

On a regional level, the percentage of outpatient visits for ILI ranged from 0.4% to 3.2% during week 47. One of the 10 regions (Region 4) reported a proportion of outpatient visits for ILI above their region-specific baseline levels.

Data collected in ILINet are used to produce a measure of ILI activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI and are compared to the average percent of ILI visits that occur during spring and fall weeks with little or no influenza virus circulation. Activity levels range from minimal, which would correspond to ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI activity from outpatient clinics being much higher than the average. Because the clinical definition of ILI is very general, not all ILI is caused by influenza; however, when combined with laboratory data, the information on ILI activity provides a clear picture of influenza activity in the United States.

During week 47, the following ILI activity levels were experienced:

One state (Georgia) experienced high ILI activity. While influenza-like illness is a non-specific term and may be caused by a variety of organisms, the increase in ILI in Georgia has occurred at the same time as a significant increase in the number of reported influenza B virus infections.New York City and one state (Alabama) experienced low ILI activity.Forty-eight states experienced minimal ILI activity (Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).Data were insufficient to calculate an ILI activity level from the District of Columbia.

Click on map to launch interactive tool

Click on map to launch interactive tool

The influenza activity reported by state and territorial epidemiologists indicates geographic spread of influenza viruses, but does not measure the severity of influenza activity.

During week 47, the following influenza activity was reported:

Regional influenza activity was reported by one state (Georgia).Local influenza activity was reported by Puerto Rico and nine states (Alabama, Connecticut, Hawaii, Louisiana, Mississippi, New York, Oklahoma, Pennsylvania, and South Carolina).Sporadic influenza activity was reported by the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states (Alaska, Arizona, Arkansas, California, Colorado, Florida, Idaho, Illinois, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oregon, Rhode Island, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).No influenza activity was reported by seven states (Delaware, Iowa, Maine, Nebraska, North Dakota, South Dakota, and Vermont).

U. S. Map for Weekly Influenza Activity


View the original article here

Monday, January 10, 2011

Update: download FluView maps and overview report for the week ending 22 February 2010 in.

Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request

FluView: A Weekly Influenza Surveillance Report Prepared by the Influenza Division

All data are preliminary and may change as more reports are received.

During week 47 (November 21-27, 2010), influenza activity in the United States remained relatively low overall, but increased slightly in the Southeast.

Of the 3,430 specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division, 366 (10.7%) were positive for influenza.The proportion of deaths attributed to pneumonia and influenza (P&I) was below the epidemic threshold. No influenza-associated pediatric deaths were reported. The proportion of outpatient visits for influenza-like illness (ILI) was 1.9%, which is below the national baseline of 2.5%. One of the 10 regions (Region 4) reported ILI above region-specific baseline levels; one state experienced high ILI activity; one state experienced low ILI activity, and 48 states experienced minimal ILI activity.The geographic spread of influenza in one state was reported as regional, Puerto Rico and nine states reported local activity; the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states reported sporadic activity; and seven states reported no influenza activity.HHS Surveillance Regions*Data for current weekData cumulative since October 3, 2010 (Week 40)Out-patient ILI†% positive for flu‡Number of jurisdictions reporting regional or widespread activity§A (H3)2009 A (H1N1)A(Subtyping not performed)BPediatric Deaths

WHO and NREVSS collaborating laboratories located in all 50 states and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and the number positive by influenza type and subtype. The results of tests performed during the current week are summarized in the table below.

Positive specimens by type/subtype

The District of Columbia and 44 states from all 10 surveillance regions have reported laboratory-confirmed influenza this season. Region 4 in the Southeastern United States has accounted for 1,231 (69.7%) of all 1,766 reported influenza viruses this season, including 680 (88.2%) of the 771 influenza B viruses.


INFLUENZA Virus Isolated
View WHO-NREVSS Regional Bar Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

This system tracks weekly counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was implemented on August 30, 2009, during the 2009 pandemic, and ended on April 4, 2010. AHDRA surveillance during the 2010-11 season is being continued on a voluntary basis and 11 jurisdictions reported during week 47. From October 3-November 27, 2010, 271 laboratory-confirmed influenza associated hospitalizations and four laboratory-confirmed influenza associated deaths were reported to CDC.


Aggregate Hospital and Death Reporting
View Full Screen | View Chart Data | View PowerPoint Presentation

CDC has antigenically characterized 18 influenza viruses [four 2009 influenza A (H1N1) viruses, eight influenza A (H3N2) viruses, and six influenza B viruses] collected by U.S. laboratories since October 1, 2010.

Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B virus isolates for resistance to neuraminidase inhibitors (oseltamivir and zanamivir) is performed at CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for a single known mutation in the neuraminidase protein of the virus that confers oseltamivir resistance (H275Y). The data summarized below combine the results of both test methods and includes samples that were tested as part of routine surveillance purposes; it does not include diagnostic testing specifically done because of clinical suspicion of antiviral resistance.

High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B viruses) circulating globally. As a result of the sustained high levels of resistance, data from adamantane resistance testing are not presented weekly in the table below.

Samples tested (n)Resistant Viruses,
Number (%)Samples tested (n)Resistant Viruses, Number (%)

To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of the need to continue hand and cough hygiene measures for the duration of any symptoms of influenza, even while taking antiviral medications. Additional information on antiviral recommendations for treatment and chemoprophylaxis of influenza virus infection is available at http://www.cdc.gov/flu/antivirals/index.htm.

During week 47, 6.0% of all deaths reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was below the epidemic threshold of 7.2% for week 47.

Pneumonia And Influenza Mortality
View Full Screen | View PowerPoint Presentation

No influenza-associated pediatric deaths were reported to CDC during week 47.

One death, associated with an influenza A virus for which the subtype was not determined, occurring during the 2010-2011 season has been reported.


Influenza-Associated Pediatric Mortality
View Full Screen | View PowerPoint Presentation

The Influenza Hospitalization Network (FluSurv-NET) conducts surveillance for population-based, laboratory-confirmed influenza-related hospitalizations in children (persons younger than 18 years) and adults. The network covers over 80 counties in the 10 Emerging Infections Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and six additional states (ID, MI, OH, OK, RI and UT). FluSurv-NET estimated hospitalization rates will be updated every two weeks starting later this season.

Nationwide during week 47, 1.9% of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness (ILI). This percentage is below the national baseline of 2.5%.

national levels of ILI and ARI
View ILINet Regional Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

On a regional level, the percentage of outpatient visits for ILI ranged from 0.4% to 3.2% during week 47. One of the 10 regions (Region 4) reported a proportion of outpatient visits for ILI above their region-specific baseline levels.

Data collected in ILINet are used to produce a measure of ILI activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI and are compared to the average percent of ILI visits that occur during spring and fall weeks with little or no influenza virus circulation. Activity levels range from minimal, which would correspond to ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI activity from outpatient clinics being much higher than the average. Because the clinical definition of ILI is very general, not all ILI is caused by influenza; however, when combined with laboratory data, the information on ILI activity provides a clear picture of influenza activity in the United States.

During week 47, the following ILI activity levels were experienced:

One state (Georgia) experienced high ILI activity. While influenza-like illness is a non-specific term and may be caused by a variety of organisms, the increase in ILI in Georgia has occurred at the same time as a significant increase in the number of reported influenza B virus infections.New York City and one state (Alabama) experienced low ILI activity.Forty-eight states experienced minimal ILI activity (Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).Data were insufficient to calculate an ILI activity level from the District of Columbia.

Click on map to launch interactive tool

Click on map to launch interactive tool

The influenza activity reported by state and territorial epidemiologists indicates geographic spread of influenza viruses, but does not measure the severity of influenza activity.

During week 47, the following influenza activity was reported:

Regional influenza activity was reported by one state (Georgia).Local influenza activity was reported by Puerto Rico and nine states (Alabama, Connecticut, Hawaii, Louisiana, Mississippi, New York, Oklahoma, Pennsylvania, and South Carolina).Sporadic influenza activity was reported by the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states (Alaska, Arizona, Arkansas, California, Colorado, Florida, Idaho, Illinois, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oregon, Rhode Island, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).No influenza activity was reported by seven states (Delaware, Iowa, Maine, Nebraska, North Dakota, South Dakota, and Vermont).

U. S. Map for Weekly Influenza Activity


View the original article here

Friday, January 7, 2011

Update: download FluView maps and overview report, for the week ending 28 days

Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request

FluView: A Weekly Influenza Surveillance Report Prepared by the Influenza Division

All data are preliminary and may change as more reports are received.

During week 47 (November 21-27, 2010), influenza activity in the United States remained relatively low overall, but increased slightly in the Southeast.

Of the 3,430 specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division, 366 (10.7%) were positive for influenza.The proportion of deaths attributed to pneumonia and influenza (P&I) was below the epidemic threshold. No influenza-associated pediatric deaths were reported. The proportion of outpatient visits for influenza-like illness (ILI) was 1.9%, which is below the national baseline of 2.5%. One of the 10 regions (Region 4) reported ILI above region-specific baseline levels; one state experienced high ILI activity; one state experienced low ILI activity, and 48 states experienced minimal ILI activity.The geographic spread of influenza in one state was reported as regional, Puerto Rico and nine states reported local activity; the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states reported sporadic activity; and seven states reported no influenza activity.HHS Surveillance Regions*Data for current weekData cumulative since October 3, 2010 (Week 40)Out-patient ILI†% positive for flu‡Number of jurisdictions reporting regional or widespread activity§A (H3)2009 A (H1N1)A(Subtyping not performed)BPediatric Deaths

WHO and NREVSS collaborating laboratories located in all 50 states and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and the number positive by influenza type and subtype. The results of tests performed during the current week are summarized in the table below.

Positive specimens by type/subtype

The District of Columbia and 44 states from all 10 surveillance regions have reported laboratory-confirmed influenza this season. Region 4 in the Southeastern United States has accounted for 1,231 (69.7%) of all 1,766 reported influenza viruses this season, including 680 (88.2%) of the 771 influenza B viruses.


INFLUENZA Virus Isolated
View WHO-NREVSS Regional Bar Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

This system tracks weekly counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was implemented on August 30, 2009, during the 2009 pandemic, and ended on April 4, 2010. AHDRA surveillance during the 2010-11 season is being continued on a voluntary basis and 11 jurisdictions reported during week 47. From October 3-November 27, 2010, 271 laboratory-confirmed influenza associated hospitalizations and four laboratory-confirmed influenza associated deaths were reported to CDC.


Aggregate Hospital and Death Reporting
View Full Screen | View Chart Data | View PowerPoint Presentation

CDC has antigenically characterized 18 influenza viruses [four 2009 influenza A (H1N1) viruses, eight influenza A (H3N2) viruses, and six influenza B viruses] collected by U.S. laboratories since October 1, 2010.

Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B virus isolates for resistance to neuraminidase inhibitors (oseltamivir and zanamivir) is performed at CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for a single known mutation in the neuraminidase protein of the virus that confers oseltamivir resistance (H275Y). The data summarized below combine the results of both test methods and includes samples that were tested as part of routine surveillance purposes; it does not include diagnostic testing specifically done because of clinical suspicion of antiviral resistance.

High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B viruses) circulating globally. As a result of the sustained high levels of resistance, data from adamantane resistance testing are not presented weekly in the table below.

Samples tested (n)Resistant Viruses,
Number (%)Samples tested (n)Resistant Viruses, Number (%)

To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of the need to continue hand and cough hygiene measures for the duration of any symptoms of influenza, even while taking antiviral medications. Additional information on antiviral recommendations for treatment and chemoprophylaxis of influenza virus infection is available at http://www.cdc.gov/flu/antivirals/index.htm.

During week 47, 6.0% of all deaths reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was below the epidemic threshold of 7.2% for week 47.

Pneumonia And Influenza Mortality
View Full Screen | View PowerPoint Presentation

No influenza-associated pediatric deaths were reported to CDC during week 47.

One death, associated with an influenza A virus for which the subtype was not determined, occurring during the 2010-2011 season has been reported.


Influenza-Associated Pediatric Mortality
View Full Screen | View PowerPoint Presentation

The Influenza Hospitalization Network (FluSurv-NET) conducts surveillance for population-based, laboratory-confirmed influenza-related hospitalizations in children (persons younger than 18 years) and adults. The network covers over 80 counties in the 10 Emerging Infections Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and six additional states (ID, MI, OH, OK, RI and UT). FluSurv-NET estimated hospitalization rates will be updated every two weeks starting later this season.

Nationwide during week 47, 1.9% of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness (ILI). This percentage is below the national baseline of 2.5%.

national levels of ILI and ARI
View ILINet Regional Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

On a regional level, the percentage of outpatient visits for ILI ranged from 0.4% to 3.2% during week 47. One of the 10 regions (Region 4) reported a proportion of outpatient visits for ILI above their region-specific baseline levels.

Data collected in ILINet are used to produce a measure of ILI activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI and are compared to the average percent of ILI visits that occur during spring and fall weeks with little or no influenza virus circulation. Activity levels range from minimal, which would correspond to ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI activity from outpatient clinics being much higher than the average. Because the clinical definition of ILI is very general, not all ILI is caused by influenza; however, when combined with laboratory data, the information on ILI activity provides a clear picture of influenza activity in the United States.

During week 47, the following ILI activity levels were experienced:

One state (Georgia) experienced high ILI activity. While influenza-like illness is a non-specific term and may be caused by a variety of organisms, the increase in ILI in Georgia has occurred at the same time as a significant increase in the number of reported influenza B virus infections.New York City and one state (Alabama) experienced low ILI activity.Forty-eight states experienced minimal ILI activity (Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).Data were insufficient to calculate an ILI activity level from the District of Columbia.

Click on map to launch interactive tool

Click on map to launch interactive tool

The influenza activity reported by state and territorial epidemiologists indicates geographic spread of influenza viruses, but does not measure the severity of influenza activity.

During week 47, the following influenza activity was reported:

Regional influenza activity was reported by one state (Georgia).Local influenza activity was reported by Puerto Rico and nine states (Alabama, Connecticut, Hawaii, Louisiana, Mississippi, New York, Oklahoma, Pennsylvania, and South Carolina).Sporadic influenza activity was reported by the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states (Alaska, Arizona, Arkansas, California, Colorado, Florida, Idaho, Illinois, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oregon, Rhode Island, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).No influenza activity was reported by seven states (Delaware, Iowa, Maine, Nebraska, North Dakota, South Dakota, and Vermont).

U. S. Map for Weekly Influenza Activity


View the original article here

Sunday, January 2, 2011

Update: download FluView maps and overview report for the week ending 30 January 2010

Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request

FluView: A Weekly Influenza Surveillance Report Prepared by the Influenza Division

All data are preliminary and may change as more reports are received.

During week 47 (November 21-27, 2010), influenza activity in the United States remained relatively low overall, but increased slightly in the Southeast.

Of the 3,430 specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division, 366 (10.7%) were positive for influenza.The proportion of deaths attributed to pneumonia and influenza (P&I) was below the epidemic threshold. No influenza-associated pediatric deaths were reported. The proportion of outpatient visits for influenza-like illness (ILI) was 1.9%, which is below the national baseline of 2.5%. One of the 10 regions (Region 4) reported ILI above region-specific baseline levels; one state experienced high ILI activity; one state experienced low ILI activity, and 48 states experienced minimal ILI activity.The geographic spread of influenza in one state was reported as regional, Puerto Rico and nine states reported local activity; the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states reported sporadic activity; and seven states reported no influenza activity.HHS Surveillance Regions*Data for current weekData cumulative since October 3, 2010 (Week 40)Out-patient ILI†% positive for flu‡Number of jurisdictions reporting regional or widespread activity§A (H3)2009 A (H1N1)A(Subtyping not performed)BPediatric Deaths

WHO and NREVSS collaborating laboratories located in all 50 states and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and the number positive by influenza type and subtype. The results of tests performed during the current week are summarized in the table below.

Positive specimens by type/subtype

The District of Columbia and 44 states from all 10 surveillance regions have reported laboratory-confirmed influenza this season. Region 4 in the Southeastern United States has accounted for 1,231 (69.7%) of all 1,766 reported influenza viruses this season, including 680 (88.2%) of the 771 influenza B viruses.


INFLUENZA Virus Isolated
View WHO-NREVSS Regional Bar Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

This system tracks weekly counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was implemented on August 30, 2009, during the 2009 pandemic, and ended on April 4, 2010. AHDRA surveillance during the 2010-11 season is being continued on a voluntary basis and 11 jurisdictions reported during week 47. From October 3-November 27, 2010, 271 laboratory-confirmed influenza associated hospitalizations and four laboratory-confirmed influenza associated deaths were reported to CDC.


Aggregate Hospital and Death Reporting
View Full Screen | View Chart Data | View PowerPoint Presentation

CDC has antigenically characterized 18 influenza viruses [four 2009 influenza A (H1N1) viruses, eight influenza A (H3N2) viruses, and six influenza B viruses] collected by U.S. laboratories since October 1, 2010.

Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B virus isolates for resistance to neuraminidase inhibitors (oseltamivir and zanamivir) is performed at CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for a single known mutation in the neuraminidase protein of the virus that confers oseltamivir resistance (H275Y). The data summarized below combine the results of both test methods and includes samples that were tested as part of routine surveillance purposes; it does not include diagnostic testing specifically done because of clinical suspicion of antiviral resistance.

High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B viruses) circulating globally. As a result of the sustained high levels of resistance, data from adamantane resistance testing are not presented weekly in the table below.

Samples tested (n)Resistant Viruses,
Number (%)Samples tested (n)Resistant Viruses, Number (%)

To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of the need to continue hand and cough hygiene measures for the duration of any symptoms of influenza, even while taking antiviral medications. Additional information on antiviral recommendations for treatment and chemoprophylaxis of influenza virus infection is available at http://www.cdc.gov/flu/antivirals/index.htm.

During week 47, 6.0% of all deaths reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was below the epidemic threshold of 7.2% for week 47.

Pneumonia And Influenza Mortality
View Full Screen | View PowerPoint Presentation

No influenza-associated pediatric deaths were reported to CDC during week 47.

One death, associated with an influenza A virus for which the subtype was not determined, occurring during the 2010-2011 season has been reported.


Influenza-Associated Pediatric Mortality
View Full Screen | View PowerPoint Presentation

The Influenza Hospitalization Network (FluSurv-NET) conducts surveillance for population-based, laboratory-confirmed influenza-related hospitalizations in children (persons younger than 18 years) and adults. The network covers over 80 counties in the 10 Emerging Infections Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and six additional states (ID, MI, OH, OK, RI and UT). FluSurv-NET estimated hospitalization rates will be updated every two weeks starting later this season.

Nationwide during week 47, 1.9% of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to influenza-like illness (ILI). This percentage is below the national baseline of 2.5%.

national levels of ILI and ARI
View ILINet Regional Charts | View Chart Data | View Full Screen | View PowerPoint Presentation

On a regional level, the percentage of outpatient visits for ILI ranged from 0.4% to 3.2% during week 47. One of the 10 regions (Region 4) reported a proportion of outpatient visits for ILI above their region-specific baseline levels.

Data collected in ILINet are used to produce a measure of ILI activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI and are compared to the average percent of ILI visits that occur during spring and fall weeks with little or no influenza virus circulation. Activity levels range from minimal, which would correspond to ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI activity from outpatient clinics being much higher than the average. Because the clinical definition of ILI is very general, not all ILI is caused by influenza; however, when combined with laboratory data, the information on ILI activity provides a clear picture of influenza activity in the United States.

During week 47, the following ILI activity levels were experienced:

One state (Georgia) experienced high ILI activity. While influenza-like illness is a non-specific term and may be caused by a variety of organisms, the increase in ILI in Georgia has occurred at the same time as a significant increase in the number of reported influenza B virus infections.New York City and one state (Alabama) experienced low ILI activity.Forty-eight states experienced minimal ILI activity (Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).Data were insufficient to calculate an ILI activity level from the District of Columbia.

Click on map to launch interactive tool

Click on map to launch interactive tool

The influenza activity reported by state and territorial epidemiologists indicates geographic spread of influenza viruses, but does not measure the severity of influenza activity.

During week 47, the following influenza activity was reported:

Regional influenza activity was reported by one state (Georgia).Local influenza activity was reported by Puerto Rico and nine states (Alabama, Connecticut, Hawaii, Louisiana, Mississippi, New York, Oklahoma, Pennsylvania, and South Carolina).Sporadic influenza activity was reported by the District of Columbia, Guam, the U.S. Virgin Islands, and 33 states (Alaska, Arizona, Arkansas, California, Colorado, Florida, Idaho, Illinois, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oregon, Rhode Island, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).No influenza activity was reported by seven states (Delaware, Iowa, Maine, Nebraska, North Dakota, South Dakota, and Vermont).

U. S. Map for Weekly Influenza Activity


View the original article here

Friday, December 24, 2010

XML version vaccine status report now available, a daily supply of new features:

Sorry my content sorry this page fromt you could not read, I cannot read the contents of this page in: fromt.

View the original article here

Monday, March 29, 2010

the symptoms of swine flu report of 2 000 students at the University of the United States

http://news.yahoo.com/s/afp/20090906/hl_afp/healthfluusuniversity_20090906183917
the symptoms of swine flu report of 2 000 students at the University of the United States
Sun Sep 6, I have 2 h 38
SAN Francisco, California (AFP) to 2 000 students at Washington State University reported symptoms of swine flu, University officials said, in one of the largest reported outbreaks of the virus in an American College campus.
School West Coast last week introduced a blog to provide information to students for the spread of influenza a (H1N1) sudden and dramatic campus a few days at the new school term.
"We believe that we have been in contact with about 2,000 students with influenza during the first 10 days of our fall semester, said the latest publication online." "
"At this time of year, typically only see a small number of patients syndrome grippal. Fournisseurs healthcare in the local community has also seen WSU students with influenza-like illness, but we have no way of knowing what".
"We also no way to estimate the number of students is self-caring home without contacting us," said the school authorities.
They also said that they had been invited by the Department of health County "to keep track of the numbers in this way give us get a better idea of the number of students at WSU actually influence.".
University students about 19,000 added that is according to the information released the Centers for disease control and prevention (CDC), inform students how to avoid capture and spread of the virus.
WSU said started distributing autothérapeutiques kit influenza students.
"Two hundred of these kits have already been distributed with 1000 more in the process," University officials said, adding that the cases of swine flu has hitherto required hospitalization.
"The vast majority of our patients had mild symptoms and is generally better in three to five days," said University.
None of the WSU fatal. Fosse 593 related to swine flu in the United States, however, death second only to Brazil, which has saved the death 657.

Duration: 0: 5: 38.


Technorati Tags: College, disease, influenza, H1N1, fireplace, swineTopics: · symptoms of swine flu tags: College, disease, influenza, H1N1 swine, fireplace, comments from 21 March 2010, lonchecaliente 5: 08

He started in laboratory ...
Started in a place called laboratory usa

do not take the shot.

From 21 March 2010, at 17: 00 AnotherBrotherMark 08

You have some news for